Olena Garmish

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

Won Park, Ljubinka Božić-Majstorović, Dragana Milaković et al. · mAbs · 2018 · 52 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial

Seung Cheol Shim, Ljubinka Božić-Majstorović, Alfredo Berrocal Kasay et al. · Lara D. Veeken · 2019 · 47 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies

Walter Reinisch, Wayne J.G. Hellstrom, Radboud J. E. M. Dolhain et al. · Annals of the Rheumatic Diseases · 2023 · 40 citations · Full text

Medicine, Molecular Medicine, Andrology +16

Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma

Alain Lescoat, Suiyuan Huang, Patrícia Carreira et al. · JAMA Dermatology · 2023 · 37 citations · Full text

Medicine, Dermatology, Pathology +13

Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region

Alain Lescoat, Dörte Huscher, Nils Schoof et al. · Lara D. Veeken · 2022 · 26 citations · Full text

Medicine, Immunology, Internal Medicine +13